182 related articles for article (PubMed ID: 30735677)
21. Cellular uptake properties of lamotrigine in human placental cell lines: Investigation of involvement of organic cation transporters (SLC22A1-5).
Hasegawa N; Furugen A; Ono K; Koishikawa M; Miyazawa Y; Nishimura A; Umazume T; Narumi K; Kobayashi M; Iseki K
Drug Metab Pharmacokinet; 2020 Jun; 35(3):266-273. PubMed ID: 32303459
[TBL] [Abstract][Full Text] [Related]
22. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).
Tahara H; Yee SW; Urban TJ; Hesselson S; Castro RA; Kawamoto M; Stryke D; Johns SJ; Ferrin TE; Kwok PY; Giacomini KM
J Pharmacol Exp Ther; 2009 Apr; 329(1):262-71. PubMed ID: 19141711
[TBL] [Abstract][Full Text] [Related]
23. Carnitine content and expression of mitochondrial beta-oxidation enzymes in placentas of wild-type (OCTN2(+/+)) and OCTN2 Null (OCTN2(-/-)) Mice.
Shekhawat PS; Yang HS; Bennett MJ; Carter AL; Matern D; Tamai I; Ganapathy V
Pediatr Res; 2004 Sep; 56(3):323-8. PubMed ID: 15240869
[TBL] [Abstract][Full Text] [Related]
24. Human macrophage differentiation induces OCTN2-mediated L-carnitine transport through stimulation of mTOR-STAT3 axis.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Milioli M; Di Lascia M; Bernuzzi G; Dall'Asta V
J Leukoc Biol; 2017 Mar; 101(3):665-674. PubMed ID: 27733576
[TBL] [Abstract][Full Text] [Related]
25. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Okura T; Kato S; Deguchi Y
Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
[TBL] [Abstract][Full Text] [Related]
26. Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology.
Djerada Z; Feliu C; Tournois C; Vautier D; Binet L; Robinet A; Marty H; Gozalo C; Lamiable D; Millart H
J Pharm Biomed Anal; 2013 Dec; 86():100-11. PubMed ID: 23995753
[TBL] [Abstract][Full Text] [Related]
27. Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2).
Szabó K; Nagy Z; Juhász V; Zolnerciks JK; Csorba A; Tímár Z; Molnár É; Pádár P; Johnson W; Beéry E; Krajcsi P
Drug Metab Pharmacokinet; 2017 Jun; 32(3):165-171. PubMed ID: 28365301
[TBL] [Abstract][Full Text] [Related]
28. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
29. Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta.
Tupova L; Hirschmugl B; Sucha S; Pilarova V; Székely V; Bakos É; Novakova L; Özvegy-Laczka C; Wadsack C; Ceckova M
Biomed Pharmacother; 2020 Sep; 129():110506. PubMed ID: 32768979
[TBL] [Abstract][Full Text] [Related]
30. Carnitine transport: pathophysiology and metabolism of known molecular defects.
Tein I
J Inherit Metab Dis; 2003; 26(2-3):147-69. PubMed ID: 12889657
[TBL] [Abstract][Full Text] [Related]
31. Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells.
Rytting E; Audus KL
J Pharm Pharmacol; 2007 Aug; 59(8):1095-102. PubMed ID: 17725851
[TBL] [Abstract][Full Text] [Related]
32. Carnitine transport and fatty acid oxidation.
Longo N; Frigeni M; Pasquali M
Biochim Biophys Acta; 2016 Oct; 1863(10):2422-35. PubMed ID: 26828774
[TBL] [Abstract][Full Text] [Related]
33. Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta.
Grube M; Meyer Zu Schwabedissen H; Draber K; Präger D; Möritz KU; Linnemann K; Fusch C; Jedlitschky G; Kroemer HK
Drug Metab Dispos; 2005 Jan; 33(1):31-7. PubMed ID: 15486076
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2).
Zhang L; Gui T; Console L; Scalise M; Indiveri C; Hausler S; Kullak-Ublick GA; Gai Z; Visentin M
J Biol Chem; 2021; 296():100204. PubMed ID: 33334877
[TBL] [Abstract][Full Text] [Related]
35. SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.
Juraszek B; Nałęcz KA
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861504
[TBL] [Abstract][Full Text] [Related]
36. The history of antiretrovirals: key discoveries over the past 25 years.
De Clercq E
Rev Med Virol; 2009 Sep; 19(5):287-99. PubMed ID: 19714702
[TBL] [Abstract][Full Text] [Related]
37. Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine.
Ceckova M; Reznicek J; Ptackova Z; Cerveny L; Müller F; Kacerovsky M; Fromm MF; Glazier JD; Staud F
Antimicrob Agents Chemother; 2016 Sep; 60(9):5563-72. PubMed ID: 27401571
[TBL] [Abstract][Full Text] [Related]
38. Transport of L-carnitine in human corneal and conjunctival epithelial cells.
Xu S; Flanagan JL; Simmons PA; Vehige J; Willcox MD; Garrett Q
Mol Vis; 2010 Sep; 16():1823-31. PubMed ID: 21045919
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of OCTN2-mediated transport of carnitine by etoposide.
Hu C; Lancaster CS; Zuo Z; Hu S; Chen Z; Rubnitz JE; Baker SD; Sparreboom A
Mol Cancer Ther; 2012 Apr; 11(4):921-9. PubMed ID: 22389472
[TBL] [Abstract][Full Text] [Related]
40. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency.
Amat di San Filippo C; Wang Y; Longo N
J Biol Chem; 2003 Nov; 278(48):47776-84. PubMed ID: 14506273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
